Christian Chabannon, MD, PhD of Institut Paoli Calmettes, Marseilles, France and President of the EBMT 2017 Annual Meeting talks about the topics under discussion at the 2016 EBMT International Transplant Course (EBMT-ITC) in Barcelona, Spain. Dr Chabannon explains that the novel forms of cellular therapy that are being developed will be a focus of the meeting. He further talks about how new drugs affect strategies for autologous and allogeneic transplantation. Another focus will be on how the different categories of donors also contribute to change the overall strategy of how autologous or allogeneic stem cell transplantation is incorporated in the treatment of malignancies.
Get great new content delivered to your inboxSign up
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest Hemonc news and updates